11.9 C
New York
Saturday, October 31, 2026
- Advertisement -spot_img

TAG

Voceryq

Voceryq wins FDA approval for rare airway disease

The FDA approved Voceryq, a DNA immunotherapy that aims to reduce repeat surgery for adults with recurrent respiratory papillomatosis on 30 October.

Latest news

- Advertisement -spot_img